Диссертация (1144259), страница 29
Текст из файла (страница 29)
-- 2015. -- Jun 19. -- T. 427, № 12. -- C. 216678.[249] Simon R. J., Kania R. S., Zuckermann R. N., Huebner V. D., Jewell D. A.,Banville S., Ng S., Wang L., Rosenberg S., Marlowe C. K., et al. Peptoids: a modularapproach to drug discovery // Proc Natl Acad Sci U S A. -- 1992. -- Oct 15. -- T. 89, №20. -- C. 9367-71.[250] Zuckermann R. N., Kodadek T. Peptoids as potential therapeutics // Curr OpinMol Ther. -- 2009. -- Jun.
-- T. 11, № 3. -- C. 299-307.- 145 -[251] Neely A. N., Miller R. G., Holder I. A. Proteolytic activity and fatal gramnegative sepsis in burned mice: effect of exogenous proteinase inhibition // InfectImmun. -- 1994. -- Jun. -- T. 62, № 6. -- C. 2158-64.[252] Kwon Y. U., Kodadek T. Quantitative evaluation of the relative cell permeabilityof peptoids and peptides // J Am Chem Soc. -- 2007.
-- Feb 14. -- T. 129, № 6. -- C.1508-9.[253] Tan N. C., Yu P., Kwon Y. U., Kodadek T. High-throughput evaluation ofrelative cell permeability between peptoids and peptides // Bioorg Med Chem. -- 2008. - Jun 1. -- T. 16, № 11. -- C. 5853-61.[254] Johnson S. A., Stinson B. M., Go M. S., Carmona L. M., Reminick J. I., Fang X.,Baumgart T. Temperature-dependent phase behavior and protein partitioning in giantplasma membrane vesicles // Biochim Biophys Acta. -- 2010. -- Jul. -- T. 1798, № 7. -C. 1427-35.[255] Sengupta P., Hammond A., Holowka D., Baird B. Structural determinants forpartitioning of lipids and proteins between coexisting fluid phases in giant plasmamembrane vesicles // Biochim Biophys Acta.
-- 2008. -- Jan. -- T. 1778, № 1. -- C. 2032.[256] Aimon S., Manzi J., Schmidt D., Poveda Larrosa J. A., Bassereau P., Toombes G.E. Functional reconstitution of a voltage-gated potassium channel in giant unilamellarvesicles // PLoS One. -- 2011. -- T. 6, № 10. -- C. e25529.[257] Kalvodova L., Kahya N., Schwille P., Ehehalt R., Verkade P., Drechsel D.,Simons K. Lipids as modulators of proteolytic activity of BACE: involvement ofcholesterol, glycosphingolipids, and anionic phospholipids in vitro // J Biol Chem.
-2005. -- Nov 4. -- T. 280, № 44. -- C. 36815-23.[258] Kahya N. Protein-protein and protein-lipid interactions in domain-assembly:lessons from giant unilamellar vesicles // Biochim Biophys Acta. -- 2010. -- Jul. -- T.1798, № 7. -- C. 1392-8.[259] Hayashi T., Su T. P. Sigma-1 receptors (sigma(1) binding sites) form raft-likemicrodomains and target lipid droplets on the endoplasmic reticulum: roles inendoplasmic reticulum lipid compartmentalization and export // J Pharmacol Exp Ther.-- 2003.
-- Aug. -- T. 306, № 2. -- C. 718-25.[260] Watanabe S., Ilieva H., Tamada H., Nomura H., Komine O., Endo F., Jin S.,Mancias P., Kiyama H., Yamanaka K. Mitochondria-associated membrane collapse is acommon pathomechanism in SIGMAR1- and SOD1-linked ALS // EMBO Mol Med. -2016. -- Dec. -- T. 8, № 12. -- C. 1421-1437.[261] Vollrath J. T., Sechi A., Dreser A., Katona I., Wiemuth D., Vervoorts J., DohmenM., Chandrasekar A., Prause J., Brauers E., Jesse C. M., Weis J., Goswami A.
Loss offunction of the ALS protein SigR1 leads to ER pathology associated with defectiveautophagy and lipid raft disturbances // Cell Death Dis. -- 2014. -- Jun 12. -- T. 5. -- C.e1290.[262] Langa F., Codony X., Tovar V., Lavado A., Gimenez E., Cozar P., Cantero M.,Dordal A., Hernandez E., Perez R., Monroy X., Zamanillo D., Guitart X., Montoliu L.Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice //Eur J Neurosci. -- 2003. -- Oct. -- T. 18, № 8.
-- C. 2188-96.- 146 -[263] Sabino V., Cottone P., Parylak S. L., Steardo L., Zorrilla E. P. Sigma-1 receptorknockout mice display a depressive-like phenotype // Behav Brain Res. -- 2009. -- Mar17. -- T. 198, № 2. -- C. 472-6.[264] Alon A., Schmidt H. R., Wood M. D., Sahn J. J., Martin S. F., Kruse A. C.Identification of the gene that codes for the sigma2 receptor // Proc Natl Acad Sci U SA. -- 2017. -- Jul 3. -- T. 114, № 27.
-- C. 7160-7165.[265] Su T. P., Su T. C., Nakamura Y., Tsai S. Y. The Sigma-1 Receptor as aPluripotent Modulator in Living Systems // Trends Pharmacol Sci. -- 2016. -- Apr. -- T.37, № 4. -- C. 262-278.[266] Zheng H., Liu W., Anderson L. Y., Jiang Q. X. Lipid-dependent gating of avoltage-gated potassium channel // Nat Commun. -- 2011. -- T. 2. -- C.
250.[267] Korinek M., Vyklicky V., Borovska J., Lichnerova K., Kaniakova M., KrausovaB., Krusek J., Balik A., Smejkalova T., Horak M., Vyklicky L. Cholesterol modulatesopen probability and desensitization of NMDA receptors // J Physiol. -- 2015. -- May15. -- T. 593, № 10. -- C. 2279-93.[268] Li Y., Ge M., Ciani L., Kuriakose G., Westover E. J., Dura M., Covey D. F.,Freed J. H., Maxfield F. R., Lytton J., Tabas I. Enrichment of endoplasmic reticulumwith cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2bactivity in parallel with increased order of membrane lipids: implications for depletionof endoplasmic reticulum calcium stores and apoptosis in cholesterol-loadedmacrophages // J Biol Chem.
-- 2004. -- Aug 27. -- T. 279, № 35. -- C. 37030-9.[269] Cannon B., Hermansson M., Gyorke S., Somerharju P., Virtanen J. A., Cheng K.H. Regulation of calcium channel activity by lipid domain formation in planar lipidbilayers // Biophys J. -- 2003. -- Aug. -- T. 85, № 2. -- C. 933-42.[270] Purcell E. K., Liu L., Thomas P. V., Duncan R.
K. Cholesterol influences voltagegated calcium channels and BK-type potassium channels in auditory hair cells // PLoSOne. -- 2011. -- T. 6, № 10. -- C. e26289.[271] Yang Y., Wang Y. F., Yang X. F., Wang Z. H., Lian Y. T., Yang Y., Li X. W.,Gao X., Chen J., Shu Y. W., Cheng L. X., Liao Y. H., Liu K. Specific Kv1.3 blockademodulates key cholesterol-metabolism-associated molecules in human macrophagesexposed to ox-LDL // J Lipid Res. -- 2013.
-- Jan. -- T. 54, № 1. -- C. 34-43.[272] Abi-Char J., Maguy A., Coulombe A., Balse E., Ratajczak P., Samuel J. L., NattelS., Hatem S. N. Membrane cholesterol modulates Kv1.5 potassium channel distributionand function in rat cardiomyocytes // J Physiol. -- 2007. -- Aug 1. -- T. 582, № Pt 3. -C. 1205-17.[273] Wong A. Y., Hristova E., Ahlskog N., Tasse L. A., Ngsee J. K., Chudalayandi P.,Bergeron R. Aberrant Subcellular Dynamics of Sigma-1 Receptor Mutants UnderlyingNeuromuscular Diseases // Mol Pharmacol.
-- 2016. -- Sep. -- T. 90, № 3. -- C. 238-53.[274] Romanenko V. G., Fang Y., Byfield F., Travis A. J., Vandenberg C. A., RothblatG. H., Levitan I. Cholesterol sensitivity and lipid raft targeting of Kir2.1 channels //Biophys J.
-- 2004. -- Dec. -- T. 87, № 6. -- C. 3850-61.[275] Tchedre K. T., Huang R. Q., Dibas A., Krishnamoorthy R. R., Dillon G. H., YorioT. Sigma-1 receptor regulation of voltage-gated calcium channels involves a directinteraction // Invest Ophthalmol Vis Sci. -- 2008. -- Nov. -- T. 49, № 11. -- C. 49935002.- 147 -[276] Sen L., Bialecki R.
A., Smith E., Smith T. W., Colucci W. S. Cholesterolincreases the L-type voltage-sensitive calcium channel current in arterial smooth musclecells // Circ Res. -- 1992. -- Oct. -- T. 71, № 4. -- C. 1008-14..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
